Skip to main content

Study M470

Study name

Doolin K 2018

Title

Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes

Overall design

This study examined circulating concentrations of C-reactive protein, plasma tryptophan, kynurenine (KYN), kynurenic acid (KYNA) and quinolinic acid (QUIN) and whole blood mRNA expression of indolamine 2,3 dioxygenase (IDO) in patients with major depressive disorder (MDD) compared with healthy controls (HC). A diagnosis of major depression was made according to DSM-IV. Depression severity was assessed using the Hamilton depression (HAM-D) rating scale. 74 MDD patients (MDD group), 39 with a first presentation of MDD (fpMDD group) and 35 with chronic or recurrent episodes (rMDD group), and 37 HC (control group) were recruited to the study. Whole blood and plasma samples were collected. Expression of markers in whole blood were measured by PCR, circulating CRP by ELISA and KP metabolites by LC-MS/MS.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Depression; Depression;

Criteria for depression

DSM-IV diagnosed MDD, HAMD-17 > 17

Sample size

111

Tissue

Peripheral; Blood; Plasma;

Platform

MS-based; LC-MS: not reported;

PMID

29787958

DOI

10.1016/j.psyneuen.2018.05.019

Citation

Doolin K, Allers KA, Pleiner S, et al. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Psychoneuroendocrinology. 2018;95:8-17.

Metabolite

L-Tryptophan;

Kynurenic acid;

Quinolinic acid;

Kynurenine/Tryptophan ratio;

Kynurenic acid/Quinolinic acid ratio;

Quinolinic acid/Kynurenine ratio;